Study to Assess Platelet Dysfunction With Verify Now Assay
This study has been completed.
Information provided by (Responsible Party):
Nina D'Abreo, MD, Winthrop University Hospital
First received: July 19, 2010
Last updated: August 8, 2012
Last verified: August 2012
The purpose of this study is to conduct a Verify now assay to detect platelet aggregation defects in patients with Myelodysplastic syndrome(MDS), immune thrombocytopenia purpura (ITP) and myeloproliferative disorders (MPD).
Platelet Aggregation Defects
||Time Perspective: Prospective
||"In-vitro Characterization of Platelet Dysfunction in Common Hematological Disorders Using the Verify Now Assay"
Primary Outcome Measures:
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||February 2012 (Final data collection date for primary outcome measure)
verify now assay
subjects who have Myelodysplastic syndrome, immune thrombocytopenia, and myeloproliferative disorders with platelet disorders
Verify Now is a rapid, simple, point-of service assay to measure platelet aggregation. The verify now assay is designed to assess platelet function based on the ability of activated platelets to bind fibrinogen. It is hoped that this study will detect the subtle platelet functional abnormalities in patients with hematological disorders.
|Ages Eligible for Study:
||18 Years to 75 Years
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
patients with platelet defects
- Patients with common blood disorders such as immune thrombocytopenia purpura(ITP) myelodysplastic syndrome MDS)and myeloproliferative disorders (MPV)
- Patients with normal platelet counts
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01167218
|Winthrop University Hospital Oncology/Hematology Division
|Mineola, New York, United States, 11501 |
Nina D'Abreo, MD
||Nina D'abreo, MD
||Winthrop University Hospital
No publications provided
||Nina D'Abreo, MD, Principal Investigator, Winthrop University Hospital
History of Changes
|Other Study ID Numbers:
|Study First Received:
||July 19, 2010
||August 8, 2012
||United States: Institutional Review Board
Keywords provided by Winthrop University Hospital:
verify now assay for hematological disorders
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on July 30, 2015